Home
Scholarly Works
Dupilumab, severe asthma airway responses, and...
Journal article

Dupilumab, severe asthma airway responses, and SARS‐CoV‐2 serology

Authors

Bhalla A; Mukherjee M; Radford K; Nazy I; Kjarsgaard M; Bowdish DME; Nair P

Journal

Allergy, Vol. 76, No. 3, pp. 957–958

Publisher

Wiley

Publication Date

March 1, 2021

DOI

10.1111/all.14534

ISSN

0001-5148

Contact the Experts team